Cargando…
TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs
The pregnane X receptor (PXR) is an important regulator of hepatocellular carcinoma cellular resistance to antitumor drugs. Activation of PXR was modulated by the co-regulators. The target protein for the Xenopus plus end-directed kinesin-like protein (Xklp2) known as TPX2 that was previously consid...
Autores principales: | Wang, Hongbo, Chu, Fang, Zhang, Xiao-feng, Zhang, Peng, Li, Li-xin, Zhuang, Yun-long, Niu, Xiao-feng, He, Xi, Li, Zhi-jie, Bai, Ying, Mao, Da, Liu, Zhen-wen, Zhang, Da-li, Li, Bo-an |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883482/ https://www.ncbi.nlm.nih.gov/pubmed/36707511 http://dx.doi.org/10.1038/s41419-022-05537-7 |
Ejemplares similares
-
MTBP enhances the activation of transcription factor ETS-1 and promotes the proliferation of hepatocellular carcinoma cells
por: Wang, Hongbo, et al.
Publicado: (2022) -
Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma
por: Wang, Xiaochen, et al.
Publicado: (2022) -
CDK5-mediated phosphorylation and stabilization of TPX2 promotes hepatocellular tumorigenesis
por: Wang, Fuqiang, et al.
Publicado: (2019) -
PXR: a center of transcriptional regulation in cancer
por: Xing, Yaqi, et al.
Publicado: (2020) -
TPX2 silencing exerts anti-tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway
por: Huang, Dan-Hong, et al.
Publicado: (2019)